Long-Term Data Show Sustained Benefit of Siponimod (Mayzent) for Secondary Progressive MS
Click HERE to Subscribe for the MS Beacon Newsletter Jennifer Barrett April 22, 2020 Siponimod (Mayzent, Novartis) had a sustained…
Are people with Multiple Sclerosis immunosuppressed? Are folks with MS at higher risk to contract COVID19
Click HERE to Subscribe for the MS Beacon Newsletter A Video by Aaron Boster, MD Are people with Multiple Sclerosis…
Stuart Schlossman
Heat & Temperature Sensitivity – MS related
COVID-19 is unprecedented and rapidly changing situation. Get the latest public health information from CDC: https://www.coronavirus.gov Stay Healthy, Stay Home…
Stuart Schlossman
Multiple sclerosis risk 29% higher for people living in urban areas, new research reveals
COVID-19 is unprecedented and rapidly changing situation. Get the latest public health information from CDC: https://www.coronavirus.gov Stay Healthy, Stay Home…
Stuart Schlossman
“NfL” Biomarker Associated with Disability Progression in Large Swedish Study of People with MS
COVID-19 is unprecedented and rapidly changing situation. Get the latest public health information from CDC: https://www.coronavirus.gov Stay Healthy, Stay Home…
Stuart Schlossman
Multiple sclerosis and your eyes — Nystagmus; Twitching; Optic neuritis, and More
COVID-19 is unprecedented and rapidly changing situation. Get the latest public health information from CDC: https://www.coronavirus.gov Stay Healthy, Stay Home…
Stuart Schlossman
Easy to connect with the REALTALK MS, Podcast series
It’s the easiest way to connect with the RealTalk MS podcast. You’ll never miss another episode. AND…we’re sharing free bonus content available ONLY…
Stuart Schlossman
Understanding MS Progression
Published April 23, 2020 Peter Chin Group Medical Director, Neuroscience, U.S. Medical Affairs, Genentech* *While Peter was an employee at…
Stuart Schlossman
COVID-19 May Not Be Severe in MS Patients, Early Data from Italy Suggest
MAY 12, 2020 – BY MARTA FIGUEIREDO People with multiple sclerosis (MS) may not be at higher risk of developing a severe COVID-19 infection,…
Stuart Schlossman
FDA Approves Bafiertam, (a Tecfidera) Generic, for Relapsing MS
Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for Multiple Sclerosis BAFIERTAM™ (monomethyl fumarate), the bioequivalent alternative to Biogen’s…
Stuart Schlossman
